Grupo para la caracterización molecular de las neoplasias hematológicas
Leeds and York Partnership NHS Foundation Trust
Leeds, Reino UnidoPublicaciones en colaboración con investigadores/as de Leeds and York Partnership NHS Foundation Trust (1)
2018
-
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study
Haematologica, Vol. 103, Núm. 7, pp. 1209-1217